Skip to content

Clinical trials

Completed Phase 2 Gastrointestinal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 2 Status: Completed Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20043
20062
20072
20081
20092
20104
20111
20121
20131
20144
20151
20173
20182
20192
20201
20212
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center5
Amgen3
Catalysis SL2
National Institutes of Health Clinical Center (CC)2
AHS Cancer Control Alberta1
AIO-Studien-gGmbH1
Ariad Pharmaceuticals1
Beni-Suef University1
Daiichi Sankyo Co., Ltd.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms41
Colorectal Neoplasms9
Digestive System Diseases7
Digestive System Neoplasms7
Neoplasms7
Gastrointestinal Diseases6
Stomach Neoplasms5
Colonic Diseases4
Esophageal Neoplasms4
Intestinal Diseases4

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.